SW-100,99.59%

产品编号:Bellancom-115475| CAS NO:2126744-35-0| 分子式:C17H17ClN2O2| 分子量:316.78

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-115475
2000.00 杭州 北京(现货)
Bellancom-115475
2900.00 杭州 北京(现货)
Bellancom-115475
7100.00 杭州 北京(现货)
Bellancom-115475
12000.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

SW-100

产品介绍 SW-100 是一种有效的组蛋白脱乙酰基酶 6 (HDAC6) 抑制剂,IC50 值为 2.3 nM,相对于其他 HDAC 酶,对 HDAC6 的选择性至少高 1000倍。SW-100 显著提高了跨越血脑屏障的能力。
生物活性

SW-100, a selective histone deacetylase 6 (HDAC6) inhibitor with an IC50 of 2.3 nM, shows at least 1000-fold selectivity for HDAC6 relative to all other HDAC isozymes. SW-100 displays a significantly improved ability to cross the blood-brain-barrier.

体外研究

SW-100 (0.01-10 µM; 48 hours) shows obvious increase in the acetylated α-tubulin levels in a dose-dependent manner.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis

Cell Line: HEK293 cells
Concentration: 0.01, 0.1, 1, 10 µM
Incubation Time: 48 hours
Result: Showed obvious increase in the acetylated α-tubulin levels in a dose-dependent manner.
体内研究
(In Vivo)

SW-100 (20 mg/kg; i.p.; twice a day for two days) ameliorates several memory and learning impairments including novel object recognition, temporal ordering, and coordinate and categorical spatial processing in mouse model of Fragile X syndrome.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 8-10 weeks old C57BL/6 mice (Fmr1-/- mice)
Dosage: 20 mg/kg
Administration: Intraperitoneal injection; twice a day for two days
Result: Ameliorated several memory and learning impairments including novel object recognition, temporal ordering, and coordinate and categorical spatial processing in Fmr1-/- mice。
体内研究

SW-100 (20 mg/kg; i.p.; twice a day for two days) ameliorates several memory and learning impairments including novel object recognition, temporal ordering, and coordinate and categorical spatial processing in mouse model of Fragile X syndrome.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 8-10 weeks old C57BL/6 mice (Fmr1-/- mice)
Dosage: 20 mg/kg
Administration: Intraperitoneal injection; twice a day for two days
Result: Ameliorated several memory and learning impairments including novel object recognition, temporal ordering, and coordinate and categorical spatial processing in Fmr1-/- mice。
体内研究

SW-100 (20 mg/kg; i.p.; twice a day for two days) ameliorates several memory and learning impairments including novel object recognition, temporal ordering, and coordinate and categorical spatial processing in mouse model of Fragile X syndrome.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 8-10 weeks old C57BL/6 mice (Fmr1-/- mice)
Dosage: 20 mg/kg
Administration: Intraperitoneal injection; twice a day for two days
Result: Ameliorated several memory and learning impairments including novel object recognition, temporal ordering, and coordinate and categorical spatial processing in Fmr1-/- mice。
性状Solid
溶解性数据
In Vitro: 

DMSO : ≥ 125 mg/mL (394.60 mM)

* "≥" means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.1568 mL 15.7838 mL 31.5676 mL
5 mM 0.6314 mL 3.1568 mL 6.3135 mL
10 mM 0.3157 mL 1.5784 mL 3.1568 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.08 mg/mL (6.57 mM); Clear solution

    此方案可获得 ≥ 2.08 mg/mL (6.57 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH₂O 中,得到澄清透明的生理盐水溶液
  • 2.

    请依序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (6.57 mM); Clear solution

    此方案可获得 ≥ 2.08 mg/mL (6.57 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

    将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中,再用生理盐水定容至 10 mL,完全溶解,澄清透明
  • 3.

    请依序添加每种溶剂: 10% DMSO    90% corn oil

    Solubility: ≥ 2.08 mg/mL (6.57 mM); Clear solution

    此方案可获得 ≥ 2.08 mg/mL (6.57 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*以上所有助溶剂都可在 西域 网站选购。
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服